Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study, Hypertension, vol.64, pp.1299-305, 2014. ,
Endothelial dysfunction-a major mediator of diabetic vascular disease, Biochim Biophys Acta, vol.1832, pp.2216-2247, 2013. ,
Soluble epoxide hydrolase inhibition improves coronary endothelial function and prevents the development of cardiac alterations in obese insulin-resistant mice, Am J Physiol Heart Circ Physiol, vol.308, pp.1020-1029, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01850659
Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats, Am J Physiol Regul Integr Comp Physiol, vol.288, pp.188-96, 2005. ,
Modulation of cytochrome-derived epoxyeicosatrienoic acids pathway: a promising pharmacological approach to prevent endothelial dysfunction in cardiovascular diseases?, Pharmacol Ther, vol.131, pp.1-17, 2011. ,
Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health, Annu Rev Pharmacol Toxicol, vol.53, pp.37-58, 2013. ,
Epoxyeicosatrienoic acids contribute with altered NO and endothelin-1 pathways to conduit artery endothelial dysfunction in essential hypertension, Circulation, vol.125, pp.1266-75, 2012. ,
Inhibition of soluble epoxide hydrolase attenuates endothelial dysfunction in animal models of diabetes, obesity and hypertension, Eur J Pharmacol, vol.654, pp.68-74, 2011. ,
Cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids contribute to insulin sensitivity in mice and in humans, Diabetologia, vol.60, pp.1066-75, 2017. ,
A sensitive LC-MS/ MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation, Anal Bioanal Chem, vol.409, pp.1845-55, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01928046
Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors, J Hypertens, vol.35, pp.1204-1216, 2017. ,
Nanobody based immunoassay for human soluble epoxide hydrolase detection using polymeric horseradish peroxidase (PolyHRP) for signal enhancement: the rediscovery of PolyHRP?, Anal Chem, vol.89, pp.6248-56, 2017. ,
Improved radiolabeled substrates for soluble epoxide hydrolase, Anal Biochem, vol.231, pp.188-200, 1995. ,
Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects, Diabetes Care, vol.21, pp.271-278, 1998. ,
Impaired flow-mediated vasodilation in type 2 diabetes: lack of relation to microvascular dysfunction, Microvasc Res, vol.76, pp.61-66, 2008. ,
Determinants of vascular function in patients with type 2 diabetes, Cardiovasc Diabetol, vol.11, p.127, 2012. ,
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women, J Am Coll Cardiol, vol.40, pp.505-515, 2002. ,
Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients, J Hypertens, vol.25, pp.361-367, 2007. ,
High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells, Circulation, vol.96, issue.1, pp.25-33, 1997. ,
Hyperglycaemia enhances nitric oxide production in diabetes: a study from South Indian patients, PLoS ONE, vol.10, p.125270, 2015. ,
convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research ,
, Choose BMC and benefit from
Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus, Diabetologia, vol.35, pp.771-777, 1992. ,
Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus, Diabetologia, vol.43, pp.1435-58, 2000. ,
Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease, Hypertension, vol.51, pp.1379-85, 2008. ,
Elevated level of pro-inflammatory eicosanoids and EPC dysfunction in diabetic patients with cardiac ischemia, Prostaglandins Other Lipid Mediat, pp.15-21, 2013. ,
Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet, J Clin Invest, vol.94, pp.2414-2434, 1994. ,
Downregulation of renal CYP-derived eicosanoid synthesis in rats with diet-induced hypertension, Hypertension, vol.42, pp.594-603, 2003. ,
Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver, Cancer Sci, vol.95, pp.520-529, 2004. ,
Increasing or stabilizing renal epoxyeicosatrienoic acid production attenuates abnormal renal function and hypertension in obese rats, Am J Physiol Renal Physiol, vol.293, pp.342-351, 2007. ,
Expression and regulation of soluble epoxide hydrolase in adipose tissue, Obesity (Silver Spring), vol.18, pp.489-98, 2010. ,
Inhibition of soluble epoxide hydrolase attenuates high-fat-diet-induced hepatic steatosis by reduced systemic inflammatory status in mice, PLoS ONE, vol.7, p.39165, 2012. ,
Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo, Proc Natl Acad Sci USA, vol.104, pp.9018-9041, 2007. ,
Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease, Cardiovasc Diabetol, vol.17, p.29, 2018. ,
Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes, Cardiovasc Diabetol, vol.16, p.50, 2017. ,
Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans, Circulation, vol.110, pp.438-481, 2004. ,
Insulinmediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release, J Clin Invest, vol.94, pp.1172-1181, 1994. ,
Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans, J Clin Invest, vol.96, pp.786-92, 1995. ,
N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase, Cardiovasc Res, vol.93, pp.120-129, 2012. ,
Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase, Sci Rep, vol.5, p.13524, 2015. ,
Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo, Circulation, vol.97, pp.1695-701, 1998. ,
Hyperglycemia rapidly suppresses flowmediated endothelium-dependent vasodilation of brachial artery, J Am Coll Cardiol, vol.34, pp.146-54, 1999. ,
Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E, J Am Coll Cardiol, vol.36, pp.2185-91, 2000. ,
Ascorbate restores endothelium-dependent vasodilation impaired by acute hyperglycemia in humans, Circulation, vol.103, pp.1618-1641, 2001. ,
Insulin causes endothelial dysfunction in humans: sites and mechanisms, Circulation, vol.105, pp.576-82, 2002. ,
Insulin impairs endothelium-dependent vasodilation independent of insulin sensitivity or lipid profile, Am J Physiol Heart Circ Physiol, vol.286, pp.76-82, 2004. ,
Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids, Circ Res, vol.81, pp.258-67, 1997. ,
Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy, Nature, vol.552, pp.248-52, 2017. ,
Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance, Proc Natl Acad Sci USA, vol.108, pp.9038-9081, 2011. ,